跳至主要内容
临床试验/IRCT20190208042654N5
IRCT20190208042654N5尚未招募3 期

Evaluation of the effectiveness of Cyproheptadine on paroxysmal short-time headache in children between 2 to 15 years of age: A single-arm clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 15 years(—)
性别
All

入选标准

  • Children with 2 to 15 years of age
  • Children with episodic paroxysmal hemicrania referred to neurology clinic whose disease has been definitively diagnosed according to the ICHD criteria.
  • Number of attacks of equal or more than once a week

排除标准

  • Patients' unwillingness to cooperate during the study
  • Severe and uncontrollable side effects of cyproheptadine
  • If, based on possible laboratory or imaging findings, a diagnosis other than episodic paroxysmal hemicrania is made during the study
  • Epilepsy or epileptic headaches
  • Existence of structural anomalies in MRI imaging
  • History of allergies to similar drugs
  • Inability to record data on the number, duration, and severity of headaches
  • Taking a prophylactic drug other than Cyproheptadine
  • Severe psychiatric problems such as depression or ADHD

研究者

相似试验